Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trellus HealthLSE:TRLS EV-to-OCF is 0.14 as of Sep. 02, 2026, which is 67% below its 10-year median of 0.43. The stock has 2 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Trellus Health ranks better than 72.62% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Trellus Health's Enterprise Value is £-0.64 Mil.
Trellus Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2025 was £-4.74 Mil. Therefore, Trellus Health's EV-to-OCF for today is 0.14.
The historical rank and industry rank for Trellus Health's EV-to-OCF or its related term are showing as below:
LSE:TRLS'
s EV-to-OCF Range Over the Past 10 Years
Min: -0.13 Med: 0.43 Max: 0.56
Current: 0.13
During the past 5 years, the highest EV-to-OCF of Trellus Health was 0.56. The lowest was -0.13. And the median was 0.43.
LSE:TRLS's EV-to-OCF is ranked better than 72.62% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 9.02
vs LSE:TRLS: 0.13
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Trellus Health's PE Ratio (TTM) for today is calculated as:
Trellus Health's share price for today is £0.0012.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trellus Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was £-0.039.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Trellus Health EV-to-OCF Related Terms
Trellus Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Trellus Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Trellus Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trellus Health EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Trellus Health's EV-to-OCF falls into.
Trellus Health's current Enterprise Value is £-0.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trellus Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2025 was £-4.74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trellus Health (LSE:TRLS) has a EV-to-OCF of 0.14 as of Sep. 02, 2026. This is 67% below median its historical median of 0.43. According to the industry distribution chart, Trellus Health ranks #187 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 27.4%.
Is Trellus Health's EV-to-OCF too high?
Trellus Health's current EV-to-OCF of 0.14 is 67% below median its 10-year median of 0.43. The Healthcare Providers & Services industry median EV-to-OCF is 9.02. Trellus Health's value of 0.14 is 98.4% below this industry median. Based on the distribution chart, Trellus Health ranks #187 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Trellus Health's EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Trellus Health ranks #187 out of 683 companies for EV-to-OCF. This puts Trellus Health in the upper half of its industry. The industry median EV-to-OCF is 9.02. Trellus Health's value of 0.14 is 98.4% below this benchmark. While the company's 10-year median is 0.43 vs. the industry median of 9.02, Trellus Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 9.02, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trellus Health's current EV-to-OCF of 0.14 is 98.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 9.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trellus Health's current EV-to-OCF is 0.14, which is 67% below median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current EV-to-OCF of 0.14. The current EV-to-OCF is 0.14, which is 67% below median its 10-year median of 0.43 and 98.4% below the Healthcare Providers & Services industry median of 9.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current EV-to-OCF is 0.14 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:TRLS has been successfully added to your 
